Bharat Biotech says COVID-19 vaccine Covaxin shows 81% efficacy in interim analysis


India had approved the vaccine, branded Covaxin, in January without late-stage efficacy data, raising questions about its effectiveness

Bharat Biotech’s home-grown COVID-19 vaccine Covaxin has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the company said on March 3.

Also read: Coronavirus | Hyderabad CSIR lab helped develop key molecule for Covaxin

The interim analysis was based on 43 recorded cases of COVID-19 in the trial of 25,800 participants, conducted in partnership with the government’s medical research body.

Thirty-six of the 43 cases were recorded in participants who received a placebo, compared with seven cases in people who were given the Bharat Biotech vaccine, pointing to an efficacy rate of 80.6%, the company said.

India had approved the vaccine, branded Covaxin, in January without late-stage efficacy data, raising questions about its effectiveness.

Also read: Brazil signs COVID-19 vaccine deal with Bharat Biotech

India’s vaccination drive, currently underway, includes Covaxin and a vaccine developed by Oxford University and AstraZeneca.

Earlier this week, Prime Minister Narendra Modi was inoculated with the first dose of Covaxin.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.